{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-030726","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2023-08-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.911211+00:00","generated_at":"2026-06-11T01:07:06.185077+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"InspireMD: C-Guardians 30-day results abstract accepted for VIVA23 presentation","bullets":["Abstract of 30-day results from C-Guardians IDE trial accepted as late-breaking presentation at VIVA23 (Oct 30-Nov 2, Las Vegas) on Nov 1, 2023, by Dr. Chris Metzger.","Trial enrolled 316 patients across 25 U.S. and European sites; includes symptomatic and asymptomatic carotid artery stenosis patients.","Primary endpoint: composite of death, all stroke, MI through 30 days and ipsilateral stroke 31-365 days; performance goal: upper bound 95% CI <11.6%.","CEO expects one-year data in H2 2024; if positive, may support PMA and potential U.S. launch of CGuard Prime EPS in H1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-030726","json":"https://secwatch.observer/filing/0001493152-23-030726.json","markdown":"https://secwatch.observer/filing/0001493152-23-030726.md","text":"https://secwatch.observer/filing/0001493152-23-030726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223030726/0001493152-23-030726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223030726/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T01:07:06.185077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}